Clinical Pharmacokinetic Advantages of New Drug Delivery Methods for the Treatment of Liver Tumours

This publication has 74 references indexed in Scilit:

• Chemo-Occlusion for the Treatment of Liver Cancer
  Clinical Pharmacokinetics, 1994
• Biodistribution of Lipiodol following hepatic arterial injection
  British Journal of Surgery, 1992
• Targeting liver tumors by administering liposomal doxorubicin into the hepatic artery
  International Journal of Cancer, 1992
• Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases
  Cancer, 1991
• A phase I study of regionally administered mitomycin microcapsules for patients with colorectal liver metastases
  European Journal of Cancer and Clinical Oncology, 1991
• Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases
  British Journal of Surgery, 1990
• Experimental and clinical status of intraperitoneal chemotherapy
  European Journal of Cancer and Clinical Oncology, 1990
• Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study
  European Journal of Cancer and Clinical Oncology, 1989
• Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterialversus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial
  Cancer, 1989
• Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium
  Cancer, 1984